Table 3-7Genotoxicity of Lead In Vitro

End pointSpecies (test
system)
ResultsaReference
With
activation
Without
activation
Salmonella typhimurium (reverse mutation); Escherichia coli (forward mutation, DNA modification); Saccharomyces cerevisia (reverse mutation); Bacillus subtilis (rec assay)Gene mutation or DNA modificationBruce and Heddle 1979; Dunkel et al. 1984; Fukunaga et al. 1982; Kharab and Singh 1985; Nestmann et al. 1979; Nishioka 1975; Rosenkranz and Poirier 1979; Simmon 1979b
S. cerevisiaeGene conversion or mitotic recombinationFukunaga et al. 1982; Kharab and Singh 1985; Nestmann et al. 1979; Simmon 1979a
E. coli RNA polymerase or Avian myetoblastosis DNA polymeraseRNA or DNA synthesisNA+Hoffman and Niyogi 1977; Sirover and Loeb 1976
Chinese hamster ovary cells; Syrian hamster embryo cellsChromosomal aberration, DNA repair, mitotic disturbanceNA+Ariza et al. 1998; Bauchinger and Schmid 1972; Costa et al. 1982; Robison et al. 1984; Zelikoff et al. 1988
Chinese hamster fibroblastsMicronucleiNA+Thier et al. 2003
Human melanoma cellsMicronucleiNA+Poma et al. 2003
Human lymphocytesStructural chromosomal aberrationNA+Beek and Obe 1974
Deknudt and Deminatti 1978
Gasiorek and Bauchinger 1981
Schmid et al. 1972
Human lymphocytesDNA double-strand breaks, DNA-protein cross-linksNA+Woźniak and Blasiak 2003
Human lymphocytesSister chromatid exchangeNABeek and Obe 1975
+Niebuhr and Wulf 1984
Human melanoma cellsSister chromatid exchangeNA+Poma et al. 2003

c = negative result; + = positive result; DNA = deoxyribonucleic acid; NA = not applicable; RNA = ribonucleic acid

From: 3, HEALTH EFFECTS

Cover of Toxicological Profile for Lead
Toxicological Profile for Lead.
Abadin H, Ashizawa A, Stevens YW, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.